The Science of AccessBio
Our methodology synthesizes the most rigorous longevity science available — epigenetic aging, regenerative medicine, precision pharmacology and exposomics — into clinically actionable protocols.
Epigenetic and biological age
We track twelve epigenetic clocks in parallel and reconcile them into a single biological-age trajectory. Members typically see measurable shifts within 90 days of starting protocol.
Regenerative medicine, responsibly
Exosomes, therapeutic peptides and senolytics are administered under physician oversight and only when biomarker evidence supports the indication. We don't chase interventions the science isn't ready for.
Independent advisory board
Our advisory board includes practicing physicians, longevity researchers and ethicists who review protocol additions quarterly and hold authority to withdraw any therapy from circulation.